Host immune responses in hepatitis C virus clearance

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 10, 2005, Pages 1089-1097

  Barrett, Sharon ^a   Sweeney, Michael ^a   Crowe, John ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Hepatitis C virus (HCV); HLA class II alleles; Spontaneous viral clearance; T cell response

Indexed keywords

HEPATITIS C VIRUS PEPTIDE; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PEPTIDE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE; VIRUS LOAD;

CELLS, CULTURED; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; REMISSION, SPONTANEOUS; T-LYMPHOCYTES;

EID: 26444592980     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200510000-00013     Document Type: Article

References (50)

1. McHutchison JG. Understanding hepatitis C. Am J Manag Care 2004; 10 (suppl 2):S21-S29.
2. Benhamou J-P, Rhodes J, Alter H. EASL international consensus conference on hepatitis C. Paris, 26-28 February 1999: consensus statement. J Hepatol 1999; 30:956-961.
3. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
4. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol 2005; 32:75-85.
5. Ward S, Lauer G, Isba R, Walker B, Klenerman P. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 2002; 128:195-203.
6. Bukh J, Forns X, Emerson SU, Purcell RH. Studies of hepatitis C virus in chimpanzees and their importance for vaccine development. Intervirology 2001; 44:132-142.
7. Mizukoshi E, Nascimbeni M, Blaustein JB, Mihalik K, Rice CM, Liang TJ, et al. Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies. J Virol 2002; 76:6093-6103.
8. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346:1006-1007.
9. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117:933-941.
10. Naumov N. HCV specific CD4+ T cells: do they help or damage? Gastroenterology 1999; 117:933-941.
11. Chang K-M, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, et al. Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33:267-276.
12. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10:439-449.
13. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191:1499-1512.
14. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:13954-13406.
15. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98:706-714.
16. Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. Hepatology 1999; 30:1088-1098.
17. Del Porto P, Puntoriero G, Scotta C, Nicosia A, Piccolella E. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment. Virology 2000; 269:313-324.
18. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002; 76:12584-12595.
19. Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR, et al. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 2004; 53:1673-1681.
20. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999; 354:2119-2124.
21. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 2000; 174:90-97.
22. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113:1675-1681.
23. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998; 29:207-213.
24. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 1998; 178:39-44.
25. Yenigun A, Durupinar B. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. J Virol 2002; 76:1787-1789.
26. Barrett S, Ryan E, Crowe J. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 1999; 30:979-983.
27. Barrett S, Ryan E, Crowe J. Influence of HLA-DQB1* alleles on disease outcome in anti-D related HCV infection [Abstract]. (Paper presented at the Digestive Disease Week 2000, San Diego, California.) Gastroenterology 2000; 118:937.
28. Fanning LJ, Levis J, Kenny-Walsh E, Wynne F, Whelton M, Shanahan F. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class Il in a homogeneous population. Hepatology 2000; 31:1334-1337.
29. McKiernan SM, Hagan R, Curry M, McDonald GS, Nolan N, Crowley J, et al. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 2000; 118:1124-1130.
30. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004; 40:108-114.
31. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184:16-21.
32. Harcourt G, Hellier S, Bunce M. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepatitis 2001; 8:174-179.
33. Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 2001; 31:1438-1446.
34. Finlay TA. Report of the Tribunal of Inquiry into the Blood Transfusion Service Board. Dublin, Ireland: Government Publications Office; 1997.
35. Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, Cockram A, et al. The natural course of hepatitis virus infection after 22 years in a unique homogeneous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49:423-430.
36. Barrett S, Kieran N, Ryan E, O'Keane C, Crowe J. Intrahepatic hepatitis C viral RNA status of serum polymerase chain reaction-negative individuals with histological changes in liver biopsy. Hepatology 2001; 33:1496-1502.
37. Jung G, Fleckenstein B, von der Mulbe F, Wessels J, Niethammer D, Wiesmuller KH. From combinational libraries to MHC ligand motifs, T-cell superagonists and antagonists. Biologicals 2001; 29:179-181. (Available at: http://www.epipredict.de - Accessed 12 December 2002.)
38. Rammensee H-G, Bachmann J, Emmerich N, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-215. (Available at: http://www.SYFPEITH.de - Accessed 12 December 2002.)
39. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25:449-458.
40. Cramp ME, Carucci P, Rossol S, Williams R, Naoumov NV. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 1999; 44:424-429.
41. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nature Medicine 2000; 6:578-582.
42. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 2003; 37:577-589.
43. Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997; 71:6011-6019.
44. Tabatabai NM, Bian TH, Rice CM, Yoshizawa K, Gill J, Eckels DD. Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein. Hum Immunol 1999; 60:105-115.
45. Harcourt G, Lucas M, Sheridan I, Barnes E, Phillips R, Klenerman P. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. J Viral Hepatitis 2004; 11:324-331.
46. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J, et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002; 185:720-727.
47. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C-positive blood donors without viremia. Hepatology 1996; 24:790-795.
48. Rico MA, Quiroga JA, Subira D, Garcia E, Castonon S, Sallberg M, et al. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol 2002; 36:408-416.
49. Schirren CA, Jung M-C, Gerlach JT, Worzfeld T, Baretton G, Mamin M, et al. Liver-derived hepatitis C virus (HCV)-specific CD4+ T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000; 32:597-603.
50. Penna A, Missale G, Lamonaca V, Pilli M, Mori C, Zanelli P, et al. Intrahepatic and circulating HLA class II-restricted hepatitis C virus-specific T cell: functional characterization in patients with chronic hepatitis C. Hepatology 2002; 35:1225-1236.